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Type 2 diabetes mellitus is a common chronic disease that is
thought to have a substantial genetic basis. Identification of
the genes responsible has been hampered by the complex
nature of the syndrome. Abnormalities in insulin secretion
and insulin action predict the development of type 2 diabe-
tes and are, themselves, highly heritable traits. Since fewer
genes may contribute to these precursors of type 2 diabetes
than to the overall syndrome, such genes may be easier to
identify. We, therefore, undertook an autosomal genomic
scan to identify loci linked to prediabetic traits in Pima
Indians, a population with a high prevalence of type 2 dia-
betes.
363 nondiabetic Pima Indians were genotyped at 516
polymorphic microsatellite markers on all 22 autosomes.
Linkage analyses were performed using three methods (sin-
gle-marker, nonparametric multipoint [MAPMAKER/SIBS],
and variance components multipoint). These analyses pro-
vided evidence for linkage at several chromosomal regions,
including 3q21-24 linked to fasting plasma insulin concen-
tration and in vivo insulin action, 4p15-q12 linked to fasting
plasma insulin concentration, 9q21 linked to 2-h insulin con-
centration during oral glucose tolerance testing, and 22q12-
13 linked to fasting plasma glucose concentration. These re-
sults suggest loci that may harbor genes contributing to type
2 diabetes in Pima Indians. None of the linkages exceeded a
LOD score of 3.6 (a 5% probability of occurring in a ge-
nome-wide scan). These findings must, therefore, be consid-
ered tentative until extended in this population or repli-
 






























Diabetes mellitus is a common chronic disease, afflicting an es-





 90%) have type 2 or non–insulin-depen-




 and the majority of these
manifest a common phenotype which includes obesity, insulin
resistance, impaired insulin secretion, and increased rates of
endogenous glucose production (2).
Substantial evidence indicates that susceptibility to type
2 diabetes is largely genetically determined (3). A relatively
rare form of diabetes, maturity onset diabetes of the young
(MODY), characterized by an early onset and transmitted as
an autosomal dominant has been associated with mutations in






















Another rare form of diabetes characterized by maternal
transmission and deafness has been associated with mutations
in mitochondrial DNA (7). Most cases of type 2 diabetes do
not follow a simple Mendelian pattern of transmission, how-
ever. Multiple genes with small to moderate effects may to
contribute to individual susceptibility in these cases. This com-
plex pattern of inheritance confounds the identification of
genes contributing to common forms of type 2 diabetes.
Studies of the genetics of type 2 diabetes may be facilitated
if genetic and phenotypic heterogeneity can be limited by care-
fully selecting relatively homogenous populations and studying
metabolic traits that are precursors of diabetes (8, 9). Type 2
diabetes is much more common in the Pima Indians of Ari-
zona than in the general U.S. population (10). Among the
Pima Indians, diabetes developing before age 45 increases the
risk of diabetes to the offspring two to fourfold (11) and segre-
gation analyses are consistent with the presence of a major
gene affecting age of onset of diabetes (12). Obesity, higher
fasting and 2-h glucose and insulin concentrations during an
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Abbreviations used in this paper:
 
 2-hour glucose, 2-h plasma glu-
cose concentration during the oral glucose tolerance test; 2-hour insu-
lin, 2-h plasma insulin concentration during the oral glucose tolerance
test; AIR, acute insulin response (3–5 min) above basal during the in-
travenous glucose tolerance test; IVGTT 10’ insulin, 10 min plasma
insulin response above basal during the intravenous glucose tolerance
test; OGTT 30’ insulin, 30 min plasma insulin concentration during


















per min) insulin infusion of
the glucose clamp; MODY, maturity onset diabetes of the young;







oral glucose tolerance test, insulin resistance, and impaired in-
sulin secretion predict the development of type 2 diabetes (11,
13) and are themselves highly heritable traits in Pima Indians
(14). The genes influencing each of these metabolic precursors
of type 2 diabetes are likely to be fewer in number and, there-
fore, may be easier to identify than those contributing to the
overall syndrome. Consequently, we undertook an autosomal
genomic scan to identify loci linked to measures of glucose tol-






363 nondiabetic Pima Indians (221 male/142 female) who
participated in a prospective study of the predictors of type 2 diabetes
between 1983 and 1996 (13) and who had at least one full sibling who
also participated in the studies were selected for the present analyses.
Since even mild impairment in glucose tolerance is associated with a
secondary impairment in insulin secretion, a subset of 231 individuals




 7.8 mM during
a 75-gram oral glucose tolerance test (15) was identified for analyses
related to insulin secretion. Table I summarizes the distribution of
sibling-pairs (sib-pairs) among the families in the entire group and
the subgroup with normal glucose tolerance. This study was approved
by the Institutional Review Board of the National Institute of Diabe-
tes and Digestive and Kidney Diseases (NIDDK) and the Tribal
Council of the Gila River Indian Community, and all subjects gave




The methods used to characterize subjects
have been described in detail elsewhere (13). Briefly, subjects were
admitted to the Clinical Research Center for 10–12 days and were
provided a weight-maintaining diet containing 50% of calories as car-
bohydrate, 30% as fat, and 20% as protein. Percent body fat and fat-
free mass were determined by hydrodensitometry and the pattern of
body fat distribution was indexed as the waist/thigh circumference ra-
tio. After at least 3 d on the metabolic diet, a 75-gram oral glucose
tolerance test (OGTT) was performed. On a subsequent day, insulin
responses to an intravenous glucose challenge (IVGTT) were mea-
sured in plasma samples obtained 3, 4, 5, 6, 8, and 10 min after the in-
jection of 25 gram of glucose. The acute insulin response (AIR) was
defined as the mean increment in plasma insulin concentration above
basal 3–5 min after the injection of glucose. As additional indices of
the acute insulin response, the 10-min insulin concentration during
the IVGTT and the 30-min insulin concentration during the OGTT
were analyzed. The former measure was chosen based on analyses
which indicate that this time point is the most highly heritable index
of insulin secretion among the Pima Indians (14). The latter index of
insulin secretion has recently been demonstrated to distinguish Finn-




 locus on chromosome 12 (16). 7–10 d after admission, glucose























SE) using a two-step hyperinsuline-
mic–euglycemic glucose clamp protocol. Glucose disposal rates were




 only) and ex-









 17.7) (17). Fasting glucose and insulin concentrations
were determined on at least three separate days during the period of
metabolic testing and the means of these measurements were used in
subsequent analyses. Many of the subjects were evaluated on more
than one occasion in the course of the longitudinal study, but only
data from their initial visit are included in the present analyses. The





Subjects were genotyped at 516 polymorphic micro-
satellite markers distributed on all 22 autosomes. The majority of
genotypes were determined by the Marshfield Medical Research
Foundation using fluorescent or radioactive-labeled primers (18, 19).
Additional markers near specific candidate genes or within scan gaps
were genotyped at Glaxo Wellcome, Inc. (Research Triangle Park,
NC). The median heterozygosity of these markers in Pima Indians
was 0.68, and the median distance between markers was 6.4 cM
(range 0–25.6). Marker data were checked for pedigree and typing er-
rors (20). A genetic map specific for the Pima Indians was con-
structed using CRI-MAP (21). The multipoint information content
(the inheritance information extracted by the markers used in the ge-












Descriptive statistical analyses were per-
formed using the procedures of the SAS Institute (Cary, NC). Fasting
insulin concentrations, insulin responses to the OGTT and IVGTT




transformed to approximate a normal distribution before analyses.
To control for the effects of age, sex, percent body fat, and body fat
distribution, multiple linear regression analyses were used to adjust
all metabolic variables for these factors prior to linkage analyses.
Measures of insulin secretion (AIR, 10-min insulin during the IVGTT




since these phenotypes also vary as a function of insulin sensitivity.
 
Table I. Distribution of Families
 
Total group Normal glucose tolerance group
 
Individuals 363 231
Nuclear families 109 71
Families with:
1 sib-pair 58 43
3 sib-pairs 28 20
6 sib-pairs 13 5
10 sib-pairs 3 1
15 sib-pairs 4 1
21 sib-pairs 2 1
36 sib-pairs 1 0
Total no. of sib-pairs 388 186
 





















































































































































SE. Measures of the acute insulin response were only
analyzed in subjects with normal glucose tolerance.
 








1330 Pima Indians geno-
typed for a larger study of the genetics of diabetes (22) from which
the present subset of subjects was drawn. Genotyping data for one




30% of subjects, whereas data on both par-
ents was available in only a small minority of individuals. The propor-
tion of alleles identical by descent was estimated and single-marker
nonparametric sib-pair linkage analyses were performed using the
SIBPAL procedure of the Statistical Analysis for Genetic Epide-
miology package (S.A.G.E. 2.2, 1994). Multipoint analyses were
performed using the MAPMAKER/SIBS program (23) to directly es-
timate the proportion of alleles identical by descent and the Hase-




 values were calcu-




 distribution with a modified number of degrees of
freedom (25) to adjust for the nonindependence of sib-pairs in these
analyses and converted into equivalent LOD scores assuming a one-
tailed test and a chi-square distribution (26). Multipoint linkage anal-
yses were also performed using a variance components method (27).





) is estimated as a fixed effect and the variance in the trait is
partitioned into three random effects: a monogenic component linked







), a polygenic component representing







) and an environmental component incor-







). The parameters of
these models are estimated by maximizing the likelihood over all sib-
ships using the scoring algorithm (28), under the assumption that the
trait is normally distributed. The null hypothesis of no linkage was







 was constrained to equal 0. These anal-
yses also used the MAPMAKER/SIBS algorithm to estimate the
proportion of alleles identical by descent. Linkage analyses used all
possible sib-pairs, but were not extended to other degrees of relation-
ships. Analyses with measures of glucose tolerance and insulin action
were performed in the entire group of nondiabetic subjects, whereas
those with measures of insulin secretion were restricted to individuals













0.01) in single-marker and multipoint nonparametric and vari-





5 loci per phenotype tested would be expected to ex-
ceed of LOD of 1.2 by chance, alone (29). However, no attempt was
made to adjust for multiple trait testing in these exploratory analyses.










ing or 2-h glucose or insulin concentrations in either single-
marker, multipoint or variance components linkage analyses
(Tables III and IV). 19 loci showed evidence of linkage to
measures of insulin secretion (Table V) and 12 loci showed ev-
idence of linkage to insulin action (Table VI). Among the loci




1.2, eight regions of interest were identi-
fied based on the strength of the linkage result, correspon-
dence of linkage results among multiple methods of analysis,
or concordance among closely related phenotypes.




showed evidence for linkage to fasting insulin concentrations
(multipoint LOD scores of 1.72 and 1.49 with MAPMAKER/
SIBS and variance components method, respectively; Table




) at physiologic insulin concentra-
tions (multipoint LOD scores of 2.48 and 1.13, respectively;





 1.50; Table VI) for linkage with insulin action at max-


















 2.31; Table IV) to the 2-h















 1.2) to Adjusted Fasting and 2-h Glucose Concentrations
 
Chromosome Marker name Single marker LOD cM
Multipoint LOD
MAPMAKER/SIBS cM Variance components cM
 
Fasting glucose
1 D1S1663 1.54 217.9 0.39 218 0.09 218
2 D2S1329 0.09 0 1.00 14 1.40 0
4 D4S3248 1.45 77.6 0.13 77 0.37 79
4 D4S3243 1.87 94.3 1.30 101 0.57 95
6 D6S273 1.04 41.4 0.90 41 1.79 41
7 D7S559 0.49 191.4 0.49 191 1.23 192
8 D8S1469 0.57 10.4 1.43 8 1.72 10
22 D22S683 1.35 36.1 3.15 43 1.31 36
22 D22S270 1.75 45.6 2.99 46 2.39 46
2-h glucose
1 D1S1595 1.34 153.4 0.28 154 0.52 153
2 D2S5131 1.49 14.7 0.67 15 0.24 15
4 GATA62A11 1.85 103.2 1.78 103 0.79 103
7 D7S1802 1.26 31.5 0.77 31 0.82 32
9 D9S925 1.37 24.0 0.90 24 0.26 31
9 D9S2026 1.25 107.4 0.00 107 0.08 107
10 D10S1237 1.25 139.4 1.21 143 0.66 149
16 D16S2621 0.70 125.6 1.23 124 1.12 126
19 D19S589 0.57 75.2 1.25 76 1.14 75






showed evidence of linkage to fasting plasma insulin concen-





 1.15 at 59 cM with MAPMAKER/SIBS and 1.50
at 74 cM in variance components analyses; Table IV) and a













 2.63; Table VI). Three









9 cM showed evidence of linkage to two measures of
acute insulin secretion; the 10-min insulin concentration during




 1.27 in variance components
analyses; Table V) and the 30-min insulin concentration during




 1.48 using MAPMAKER/
SIBS; Table V).








 (76.1 cM) showed evidence of linkage to fasting and





both methods; Table IV) (Fig. 2). A second peak on chromo-








(98.8 cM) showed even greater evidence of linkage to 2-h




 1.94 and 2.16
with MAPMAKER/SIBS and variance components methods;














 (108.7 cM) on 11q13,
contained four markers (
 
D11S1975-D11S2371-D11S1396-
D11S2000) with evidence of linkage to the 2-h insulin during
the OGTT (single marker LOD 5 1.23–2.04, multipoint LOD
1.31 using MAPMAKER/SIBS; Table IV). A fifth marker in
this region, D11S1396, also showed evidence of linkage to fast-
ing plasma insulin concentration (single marker LOD 5 1.52;
Table IV). Chromosome 12 contained a region flanked by
D12S1052 (80.7 cM) and D12S1297 (89 cM) with evidence of
linkage to 2-h OGTT insulin concentration (single marker
LOD 5 1.32; Table IV) and Mhigh (multipoint LOD scores 5
2.05 and 1.20 in MAPMAKER/SIBS and variance components
analyses; Table IV). 
Two regions of interest were identified on chromosome 22.
The p-terminal end contained a locus (D22S420) with evi-
dence for linkage to Mhigh (multipoint LOD 5 1.90 and 2.12 us-
ing MAPMAKER/SIBS and variance components methods;
Table VI & Fig. 3) while 22q12-13 contained two markers,
D22S683 at 36.1 cM and D22S270 at 45.6 cM, showing evi-
dence of linkage to fasting glucose concentration (Fig. 3).
These latter loci provided the strongest evidence of linkage to
a prediabetic phenotype obtained in this genome scan (multi-
Table IV. Markers Linked (LOD $ 1.2) to Adjusted Fasting and 2-h Insulin Concentrations
Chromosome Marker name Single marker LOD cM
Multipoint LOD
MAPMAKER/SIBS cM Variance Components cM
Fasting insulin
3 D3S2403 0.03 32.0 1.12 32 1.30 35
3 D3S3038 1.59 42.2 1.35 40 1.25 45
3 D3S1764 1.48 149.9 1.72 150 1.49 150
3 D3S2427 1.14 188.4 0.91 188 1.22 188
4 D4S2629 1.99 53 0.64 53 0.29 53
4 D4S2382 2.75 58.3 1.15 59 0.89 61
4 D4S1627 2.02 66 0.68 66 0.98 67
4 D4S3242 1.34 68 1.09 72 1.15 68
4 D4S3248 0.60 77.6 0.84 77 1.50 74
9 D9S1123 1.64 63.1 1.44 68 0.66 63
9 D9S1120 0.37 76.1 0.49 76 1.42 70
11 D11S1396 1.52 92.2 0.25 92 0.09 92
19 D19S714 0.63 20.5 0.30 20 1.33 18
2-h insulin
3 D3S1744 2.31 157.8 1.38 160 1.07 160
3 D3S3053 1.37 181.1 0.34 179 0.42 181
7 D7S3061 2.56 131.7 1.78 131 0.86 131
9 D9S168 1.01 10.0 1.84 17 0.48 20
9 D9S903 1.22 69.3 0.83 69 1.46 69
9 D9S910 1.63 95.5 1.53 96 2.03 96
9 D9S938 0.45 98.8 1.94 99 2.16 98
11 D11S1975 1.61 79.0 0.99 79 0.38 79
11 D11S2371 2.04 82.6 1.31 83 0.46 82
11 D11S1396 1.52 92.2 0.54 92 0.22 93
11 D11S2000 1.23 108.7 0.93 108 0.80 109
12 D12S1052 1.32 80.7 0.15 85 0.27 89
15 gata50c03 0.71 30.7 0.59 31 1.50 31
16 D16S2613 1.52 19.7 0.13 20 0.70 20
16 D16S2621 1.29 125.6 1.33 126 0.52 126
All variables were adjusted for age, sex, percent fat, and waist/thigh ratio.
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point LOD scores 5 3.15 and 2.39 in MAPMAKER/SIBS and
variance components analyses, respectively; Table III).
Discussion
To identify potential genetic determinants of type 2 diabetes,
we performed an autosomal genomic scan to search for evi-
dence of linkage to prediabetic metabolic phenotypes in 363
well characterized nondiabetic Pima Indians from 109 nuclear
families. These analyses identified several regions with evi-
dence of linkage to aspects of glucose metabolism which pre-
dict type 2 diabetes in Pima Indians.
On chromosome 3, the linkage to fasting plasma insulin
concentration and insulin action at physiologic insulin concen-
trations at D3S1764 maps to 3q21-24. The structural gene for
glycogenin (GYG) is a potential candidate gene located in this
region. Glycogenin initiates glycogen formation (30), the main
pathway of glucose disposal (and therefore insulin action) dur-
ing the hyperinsulinemic glucose clamp (2). Another potential
candidate in this region is an expressed sequence with similar-
ity to the phosphatidyl inositol-3-kinase beta catalytic subunit.
Phosphatidyl inositol-3-kinase is a key enzyme in insulin signal
transduction.
The region of interest on chromosome 4 flanked by D4S2629
and D4S3248 with evidence of linkage to fasting plasma insulin
concentration maps to 4p15-q12 and contains the gene en-
coding the vitamin D binding–protein (also known as group-
specific component). Polymorphisms in the vitamin D bind-
ing–protein are associated with fasting insulin concentrations
in the Dogrib Indians (31) and, in elderly Dutch men, low vita-
min D levels are associated with glucose intolerance and hy-
perinsulinemic responses during an OGTT (32).
There are no obvious candidate genes in the region on
chromosome 8 with evidence of linkage to measures of insulin
secretion (flanked by D8S1132-D8S592 mapping to 8p22-23).
In contrast, the region on chromosome 9 with evidence of link-
age to 2-h OGTT insulin concentration (markers D9S910 and
D9S938 mapping to 9q21-22) contains several genes including
those encoding hepatic fructose-1,6 bisphosphatase and aldo-
lase B. Hepatic fructose-1,6 bisphosphatase, a rate-limiting en-
zyme in gluconeogenesis, has been investigated as a candidate
gene, but two highly informative flanking markers showed no
evidence of linkage to type 2 diabetes in either Caucasian or
African-American families (33). Mutations in aldolase B are a
cause of hereditary fructose intolerance, but have not been im-
plicated in type 2 diabetes.
The region on chromosome 11 flanked by D11S1975 and
D11S2000 (11q13) with evidence of linkage to the 2-h OGTT
insulin concentration is a broad (z 30 cm) area containing
many genes encoding diverse proteins. The gene for uncou-
pling protein-2, which is linked to a quantitative trait locus for
insulin concentrations in mice, has recently been mapped to
this region (34) as has the recently described uncoupling pro-
tein-3 (35). Other potential candidates in this region include
galanin (GALN), a neuropeptide that inhibits insulin secre-
tion and influences feeding behavior, phospholipase C-beta-3
(PLCB3), protein tyrosine kinase 1 (MLK3), the catalytic al-
pha subunit of protein phosphatase type 1 (PPP1CA), the PTP
Table V. Markers Linked (LOD $ 1.2) to Adjusted Insulin Secretion
Chromosome Marker name Single marker LOD cM
Multipoint LOD
MAPMAKER/SIBS cM Variance components cM
AIR
3 D3S2406 0.44 97.0 0.34 96 1.24 94
4 D4S415 1.08 192.6 1.05 193 1.57 193
5 D5S820 1.41 170.8 0.70 165 0.35 172
7 D7S2201 1.81 4.4 0.00 4 0.09 4
7 D7S798 0.62 180.4 1.49 183 0.28 181
IVGTT 109 insulin
3 D3S3026 1.57 66.8 0.92 67 0.71 67
3 D3S3054 1.24 214.2 0.64 214 0.91 214
5 D5S2505 1.65 16.7 0.97 17 0.76 17
7 D7S559 1.79 191.4 1.78 190 0.75 189
8 D8S1132 0.74 111.8 0.73 112 1.27 112
8 GATA101F01 1.62 115.3 0.81 115 1.11 116
15 D15S659 1.32 40.4 1.46 45 0.42 49
18 D18S64 1.12 85.5 1.42 86 0.75 94
OGTT 309 insulin
1 D1S1589 1.53 181.4 0.15 181 0.18 181
1 D1S235 1.33 252.3 1.41 258 0.72 253
3 D3S3039 1.20 98.2 1.27 98 0.21 98
8 D8S592 0.26 120.2 1.48 120 0.86 120
12 D12S1294 1.47 72.7 0.89 74 0.39 75
14 D14S748 1.15 38.6 1.87 39 0.94 40
All variables were analyzed in subjects with normal glucose tolerance and were adjusted for age, sex, percent fat, waist/thigh ratio, and Mlow.
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receptor type C subunit associated protein (PTPRCAP), and
muscle glycogen phosphorylase (PYGM). A putative IDDM
susceptibility locus (IDDM4) is also in this region (36). The re-
gion on chromosome 12 (around D12S1297) linked to insulin
action at supraphysiologic insulin concentrations (Mhigh) con-
tains a potential candidate gene, MYF5, a transcription factor
involved in the differentiation of skeletal muscle which was re-
cently shown to be regulated by insulin (37).
Chromosome 22 contained two regions of potential impor-
tance. The p-terminal region (around D22S420) showed evi-
dence of linkage to insulin action (Mhigh) while the q-terminal
region (D22S683-D22S270 mapping to 22q12-13) provided the
most significant evidence of linkage to a prediabetic pheno-
type (fasting plasma glucose concentration) in this genomic
scan. Potential candidate genes in this region include the gene
encoding the somatostatin receptor 3 (SSTR3) and the struc-
tural locus for casein kinase-1 epsilon (CSNK1E). The latter
enzyme could modulate the activity of intracellular proteins in-
volved in glucose metabolism, as do other members of this
family.
In addition to these regions of interest, we specifically ex-
amined regions in which linkage to diabetes or traits predicting
diabetes have been reported. There was no evidence of linkage
to prediabetic phenotypes near loci tentatively linked to obe-
sity or type 2 diabetes in Pima Indians (22). We also were un-
Table VI. Markers Linked (LOD $ 1.2) to Adjusted Insulin Action
Chromosome Marker name Single marker LOD cM
Multipoint LOD
MAPMAKER/SIBS cM Variance components cM
Low dose M
2 D2S1353 1.04 155.9 0.80 157 1.23 156
3 D3S1764 2.20 149.9 2.48 150 1.13 150
9 D9S168 1.77 10.0 1.44 10 0.99 10
10 D10S579 0.54 115.4 1.54 115 1.45 116
10 D10S2322 1.47 158.1 1.55 175 0.08 158
10 D10S169 1.78 181.3 1.37 181 0.03 181
High dose M
1 D1S1660 1.83 201.2 0.69 201 0.51 201
3 D3S1050 1.57 7.8 0.69 8 0.70 7
3 D3S1764 1.50 149.9 0.17 150 0.55 150
4 D4S3255 2.63 70.1 0.42 71 0.55 74
5 D5S815 0.70 109.9 0.83 109 1.73 110
12 D12S1297 1.44 89.0 2.05 87 1.20 85
22 D22S420 1.40 0 1.90 0 2.12 0
All variables were adjusted for age, sex, percent fat and waist/thigh ratio.
Figure 1. Variance components linkage analysis LOD scores for fast-
ing plasma insulin concentration (dotted line) and insulin action at 
physiologic insulin concentrations (solid line) plotted against genetic 
distance (chromosome 3).
Figure 2. Variance components linkage analysis LOD scores for fast-
ing (dotted line) and 2-h (solid line) OGTT insulin concentration plot-
ted against genetic distance (chromosome 9).
Genomic Scan for Prediabetic Phenotypes 1763
able to replicate the linkage on 1p to acute insulin response
(38) or the linkage on 4q to insulin action at maximally stimu-
lating insulin concentrations (39) previously reported in this
population. The marker set used in the present genomic scan
included markers flanking these regions, but not the actual
markers which provided the greatest evidence of linkage in
earlier studies. It is possible that the present marker set lacked
sufficient resolution to detect these linkages. Alternatively, the
earlier results may have been false positives.
There was no evidence that any prediabetic phenotype was
linked to D2S125 on distal 2q. This locus was identified as a
major susceptibility locus for type 2 diabetes (NIDDM1) in
Mexican Americans from Starr County, TX (40). The locus for
MODY3 on chromosome 12 has been linked to type 2 diabetes
in Finnish families characterized by impaired insulin secretion
(16). We found no evidence of linkage in this region to mea-
sures of insulin secretion in the Pima Indians, nor was there
any evidence of linkage at other loci implicated in MODY
(TCF14 and glucokinase). We were also unable to replicate
the linkages to fasting and 2-h glucose concentrations on chro-
mosomes 6 and 11 reported in Mexican-Americans from San
Antonio, TX (41). Finally, we examined regions containing pu-
tative loci for susceptibility to type 1 diabetes mellitus (35, 42,
43). Markers linked to aspects of glucose metabolism in the
present analyses that are near loci implicated in type 1 diabetes
include D6S273 (near IDDM1), D8S1469, D11S1975 (near
IDDM4), D14S748, and D18S64 (near IDDM6).
In summary, the results of this autosomal genomic scan
suggest several regions with evidence of linkage to aspects of
glucose metabolism in the Pima Indians. LOD scores in these
regions were , 3.6 (the threshold at which results would have
a 5% probability of occurring in a complete genome scan)
(29). Thus, these findings must be considered tentative until
extended in this population or replicated in others. Neverthe-
less, the results of these analyses do suggest chromosomal re-
gions in which there is an increased likelihood of finding genes
contributing to type 2 diabetes among the Pima Indians.
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